NUVIGIL
Pharma stocks miss rally, but this stock defies trend, zooms 60% YTD!The pharma company reported a five-fold jump in December quarter profit.
Lupin rallies on USFDA approval for generic drugAt 09:40 am, Lupin shares were trading 1.06 per cent higher at 1,533. They hit a low of Rs 1,526 and a high of Rs 1,545 in the first 30 min...
Lupin receives USFDA approval for generic drug to treat sleep disordersLupin's share prices rose 0.82% on Tuesday to close at Rs1,517.05 on BSE, where the benchmark Sensex ended 0.17% higher.
Natco Pharma's US partner gets FDA nod for wakefulness tabletsBreckenridge had filed its abbreviated new drug application (ANDA) with a Paragraph IV certification to obtain approval to manufacture.
Lupin gets US nod for Armodafinil tablets, Doxycycline capsulesDrug firm Lupin today said the company's US subsidiary has received tentative approvals for its Armodafinil tablets and Doxycycline capsule...
Load More